Disparities in Transgender Prostate Screening Uptake Driven by Clinicians
By Lori Solomon HealthDay Reporter
FRIDAY, Feb. 23, 2024 -- Clinician recommendations are the most significant factor in driving prostate-specific antigen (PSA) screening in transgender women, according to a study published online Feb. 14 in JAMA Network Open.
Sandhya Kalavacherla, from the University of California in San Diego, and colleagues sought to understand factors associated with recent PSA screening in transgender women. The analysis included 255 transgender women and 1,020 matched cisgender men participating in the 2018 and 2020 Behavioral Risk Factor Surveillance System surveys.
The researchers found that recent PSA screening rates among transgender women and cisgender men aged 55 to 69 years were 22.2 and 36.3 percent, respectively. Among those aged 70 years and older, rates were higher (41.8 and 40.2 percent, respectively). Transgender women had lower odds of recent screening than cisgender men (odds ratio [OR], 0.65; 95 percent confidence interval [CI], 0.46 to 0.92; P = 0.02). Effect size and significance were similar when accounting for time since the last primary care visit (OR, 0.61; 95 percent CI, 0.42 to 0.87; P = 0.007). However, odds were similar when accounting for whether a clinician recommended a PSA test (OR, 0.83; 95 percent CI, 0.45 to 1.27; P = 0.21). Among transgender women, having a recommendation for PSA testing was the factor most strongly associated with recent screening (OR, 12.40; 95 percent CI, 4.47 to 37.80; P < 0.001).
"These data suggest that disparities in PSA screening among transgender women may be associated with clinician patterns of care rather than differences in sociodemographic characteristics or access to care," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented...
Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income
FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...
Maternal Serum Alpha-Fetoprotein Levels Higher in Black Than White Women
FRIDAY, May 31, 2024 -- Maternal serum alpha-fetoprotein (AFP) levels are higher in Black than White pregnant women, supporting the use of accounting for these differences in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.